The next focusIR Investor Webinar takes places on 14th May with guest speakers from Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund. Please register here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksWTG.L Regulatory News (WTG)

  • There is currently no data for WTG

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Pre-close update

10 Feb 2020 07:00

RNS Number : 4117C
Watchstone Group PLC
10 February 2020
 

Watchstone Group plc

 

("Watchstone" or the "Group")

 

Pre-close update

 

Watchstone Group plc (LON:WTG) today issues a pre-close update ahead of its results for the year ended 31 December 2019.

 

During 2019, the Board continued its work to simplify the Group, resolve legacy issues, reduce costs and to commence the process for returning further capital to shareholders.

 

As announced on 7 February 2020, our Healthcare Services division in Canada was sold for an initial cash consideration of Canadian $36.2m (£20.8m) on a cash and debt free basis with up to a further C$0.8m (£0.5m) conditional on the business generating target revenues in the first year after its acquisition.

 

A number of commercial disputes were resolved in the year, the most significant of which was the High Court claim issued by Slater and Gordon (UK) 1 Limited ("S&G"). As announced on 21 October 2019, the settlement provided for £11m of the £50m held in escrow to be released to S&G with the balance of £39m and accrued interest being released to Watchstone.

 

Cash and term deposits on 31 December 2019 (excluding cash within businesses classified as held for sale) totalled £71.6m. Total cash following completion of the sale of the Healthcare Services division, is approximately £90m representing approximately 195 pence per share.

 

Capital return

 

Watchstone will now proceed with plans for a further Court approved, capital repayment to shareholders and further details will be announced in due course. Subject to shareholder approval, completion of the necessary working capital and creditor analysis (including contingent creditors) and the Court timetable, the current plan is to return at least £50m (representing at least 110p per share) before the end of June 2020. The timetable is anticipated to be slightly longer than usual given the need to complete the audit in advance of the return.

 

As further matters are resolved, the Company will seek to return additional cash to shareholders.

 

ingenie

 

Following the sale of the Healthcare Services division, Watchstone now retains one remaining operating business, ingenie. Consistent with our announcement at the half year, ingenie's retail business continued to face difficult market conditions in 2019, but significant changes have been made to increase competitiveness which are now bearing fruit with daily new policy sales at their highest levels for a number of years.

 

In November 2019, ingenie successfully launched its new self-fit proposition making its offering ever more competitive.

 

Legacy matters

 

The SFO investigation continues and we are cooperating fully. It remains the only regulatory inquiry to which the Group is subject.

 

Whilst we understand that the previously threatened class action litigation first announced in September 2015 has been abandoned, a firm purporting to act for a group of twelve individuals (some of whom participated in the original threatened litigation) has recently written a "Notice of intended claim" to the Company ("Notice"). The Notice relates to potential pursuit of a claim arising under section 90A and Schedule 10A of the Financial Services and Markets Act 2000. However, it provides no information to support the validity or valuation of the individual prospective claimants' claims, which they would be required to prove in due course in any litigation. The Company will vigorously defend all such claims if so brought.

 

2020 outlook

 

The Group's stated strategy remains to ultimately divest of its operating businesses, resolve all legacy issues and return as much capital as possible to shareholders.

 

The Board hopes that 2020 will see significant further progress to the final resolution of the Group's historic matters and a substantial return of capital to shareholders in at least one distribution (as referred to above).

 

For further information:

Watchstone Group plc 

 

 

Tel: 03333 448048

WH Ireland Limited, Nominated Adviser and broker

 

Chris Hardie

Lydia Zychowska

Tel: 020 7220 1666

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
UPDKZGGZLLNGGZM
Date   Source Headline
5th Dec 201110:54 amPRNForm 8.3 - Quindell Portfolio Plc
5th Dec 20119:58 amRNSForm 8.3 - Quindell Portfolio Plc
5th Dec 20117:00 amRNSRule 2.10 Announcement
2nd Dec 20111:39 pmRNSEarly settlement of TMS Earnout
2nd Dec 20117:00 amRNSRecommended Share Offer for Mobile Doctors
1st Dec 201110:58 amRNSForm 8.3 - Quindell Portfolio Plc
30th Nov 20112:00 pmRNSTotal Voting Rights
29th Nov 201110:36 amRNSForm 8.3 - Quindell Portfolio Plc
28th Nov 20119:07 amRNSForm 8.3 - Quindell Portfolio Plc
25th Nov 20113:54 pmRNSTMC (Southern) Ltd - Form 8.3 - Quindell
25th Nov 201110:40 amRNSForm 8.3 - Quindell Portfolio Plc
18th Nov 20117:00 amRNSAppointment of Joint Broker
17th Nov 20115:32 pmRNSForm 8 (OPD) Mobile Doctors Group Plc
17th Nov 20114:38 pmRNSJohn Stretton-Knowles - Form 8.3 - Quindell
17th Nov 20114:38 pmRNSMatthew Whiting - Form 8.3 - Quindell
17th Nov 20114:38 pmRNSNeil McGrigor - Form 8.3 - Quindell
17th Nov 20114:38 pmRNSMark Read - Form 8.3 - Quindell
17th Nov 20114:38 pmRNSSimon Rand - Form 8.3 - Quindell
17th Nov 20114:38 pmRNSTony Smith - Form 8.3 - Quindell
17th Nov 20114:38 pmRNSJames Eneas - Form 8.3 - Quindell
17th Nov 20114:38 pmRNSDominic Milton - Form 8.3 - Quindell
17th Nov 20114:38 pmRNSTMC (Southern) Limited - Form 8.3 - Quindell
17th Nov 20114:37 pmRNSBradley Wingrave - Form 8.3 - Quindell
17th Nov 20114:37 pmRNSForm 8 (OPD) (Quindell Portfolio Plc)
17th Nov 20114:37 pmRNSForm 8 (OPD) (Mobile Doctors)
17th Nov 20114:37 pmRNSRule 2.10 Announcement
10th Nov 20117:00 amRNSPartnership with SMI Telecoms LLC
7th Nov 20112:57 pmRNSForm 8.3 - Quindell Portfolio Plc
4th Nov 20119:54 amRNSPossible Offer for Mobile Doctors
1st Nov 20117:00 amRNSAcquisition of Maine Finance Limited
31st Oct 20117:00 amRNSTotal Voting Rights
26th Oct 20117:00 amRNSIntegration of Acquired Businesses
21st Oct 201110:58 amRNSDirector Shareholdings/Significant Shareholders
19th Oct 201110:56 amRNSDirector/PDMR Shareholding
19th Oct 20119:56 amRNSDirector/PDMR Shareholding
19th Oct 20117:00 amRNSFurther Investment in Mobile Doctors Group plc
17th Oct 201110:00 amRNSDirector/PDMR Shareholding
17th Oct 20117:00 amRNSSeven new Contract wins and Trading Update
10th Oct 20117:10 amRNSFurther Investment in Mobile Doctors Group plc
10th Oct 20117:00 amRNSAppointment of Financial PR Advisor
1st Aug 20117:00 amRNSTotal Voting Rights
25th Jul 20117:01 amRNSDirector/PDMR Shareholding
25th Jul 20117:01 amRNSInvestment in MDG.L and Board Appointment
25th Jul 20117:00 amRNSHalf Yearly Report
22nd Jul 20117:00 amRNSAcquisition
21st Jul 20117:00 amRNSInvestment in digital insurance brand Ingenie
18th Jul 20117:00 amRNSChange of Name
14th Jul 201111:24 amRNSIssue of Warrants
14th Jul 201111:23 amRNSResults of General Meeting
11th Jul 20114:02 pmRNSChanges to significant shareholdings

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.